#Pharma ailleurs #Bourse Bon pour #Sanofi aux USA - Novo In Need Of A Booster Shot - http://t.co/xExw1tlxGD cc @MTU31
July 05, 2013
Publicité
/http%3A%2F%2Fstatic2.cdn-seekingalpha.com%2Fimages%2Funiversal%2Flogo_for_linkedin.jpg)
Novo In Need Of A Booster Shot
The once-unstoppable Novo Nordisk ( NVO) has hit a bad patch, its shares defying big-cap market trends and declining over the first half of 2013 after the FDA sent long-acting insulins Tresiba and Ryzodeg back to the clinic for years of remedial work (Biotech continues to reward investors in first half, July 3, 2012).